AP2743A - Macrocyclic indole derivatives useful as hepatitisC virus inhibitors - Google Patents

Macrocyclic indole derivatives useful as hepatitisC virus inhibitors

Info

Publication number
AP2743A
AP2743A AP2010005521A AP2010005521A AP2743A AP 2743 A AP2743 A AP 2743A AP 2010005521 A AP2010005521 A AP 2010005521A AP 2010005521 A AP2010005521 A AP 2010005521A AP 2743 A AP2743 A AP 2743A
Authority
AP
ARIPO
Prior art keywords
indole derivatives
derivatives useful
virus inhibitors
macrocyclic indole
hepatitisc
Prior art date
Application number
AP2010005521A
Other languages
English (en)
Other versions
AP2010005521A0 (en
Inventor
Sandrine Marie Helene Vendeville
Piere Jean-Marie Bernard Raboisson
Tse-I Lin
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of AP2010005521A0 publication Critical patent/AP2010005521A0/xx
Application granted granted Critical
Publication of AP2743A publication Critical patent/AP2743A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D515/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AP2010005521A 2008-07-08 2009-07-08 Macrocyclic indole derivatives useful as hepatitisC virus inhibitors AP2743A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP08159965 2008-07-08
EP08160254 2008-07-11
EP08161743 2008-08-04
PCT/EP2009/004942 WO2010003658A1 (en) 2008-07-08 2009-07-08 Macrocyclic indole derivatives useful as hepatitis c virus inhibitors

Publications (2)

Publication Number Publication Date
AP2010005521A0 AP2010005521A0 (en) 2010-12-31
AP2743A true AP2743A (en) 2013-09-30

Family

ID=40972916

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2010005521A AP2743A (en) 2008-07-08 2009-07-08 Macrocyclic indole derivatives useful as hepatitisC virus inhibitors

Country Status (32)

Country Link
US (2) US8921355B2 (hu)
EP (1) EP2310396B1 (hu)
JP (2) JP5426671B2 (hu)
KR (1) KR101640374B1 (hu)
CN (1) CN102089314B (hu)
AP (1) AP2743A (hu)
AR (1) AR072726A1 (hu)
AU (1) AU2009267389B8 (hu)
BR (1) BRPI0915887B8 (hu)
CA (1) CA2729307C (hu)
CL (1) CL2011000032A1 (hu)
CO (1) CO6351793A2 (hu)
CR (1) CR20110076A (hu)
DK (1) DK2310396T3 (hu)
EA (1) EA019008B1 (hu)
EC (1) ECSP11010750A (hu)
ES (1) ES2651038T3 (hu)
HK (1) HK1155734A1 (hu)
HN (1) HN2011000072A (hu)
HR (1) HRP20171892T1 (hu)
HU (1) HUE035244T2 (hu)
IL (1) IL210086A (hu)
LT (1) LT2310396T (hu)
MX (1) MX2011000276A (hu)
NI (1) NI201100010A (hu)
NO (1) NO2310396T3 (hu)
NZ (2) NZ603343A (hu)
SI (1) SI2310396T1 (hu)
SV (1) SV2011003796A (hu)
TW (1) TWI454476B (hu)
UY (1) UY31973A (hu)
WO (1) WO2010003658A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0821836A2 (pt) 2007-12-24 2015-06-16 Tibotec Pharm Ltd Indóis macrocíclicos como inibidores do vírus da hepatite c
TWI454476B (zh) * 2008-07-08 2014-10-01 Tibotec Pharm Ltd 用作ｃ型肝炎病毒抑制劑之巨環吲哚衍生物
UA108211C2 (uk) * 2009-11-04 2015-04-10 Янссен Рід Айрленд Бензімідазолімідазольні похідні
KR20130057990A (ko) * 2010-04-13 2013-06-03 얀센 파마슈티칼즈, 인코포레이티드 마크로사이클릭 ｈｃｖ 저해제, 비뉴클레오시드 및 뉴클레오시드의 배합물
US9127010B2 (en) 2010-06-24 2015-09-08 Janssen Sciences Ireland Uc Preparation of 13-cyclohexyl-3-methoxy-6-[methyl-(2-{2-[methyl-(sulphamoyl)-amino]-ethoxy}-ethyl)-carbamoyl]-7H-indolo-[2,1-a]-[2]-benzazepine-10-carboxylic acid
EP2760821B1 (en) 2011-09-02 2017-10-11 Novartis AG Choline salt of an anti-inflammatory substituted cyclobutenedione compound
US8716275B2 (en) * 2011-10-20 2014-05-06 Bristol-Myers Squibb Company Compound for the treatment of hepatitis C
CN104780921A (zh) 2012-08-31 2015-07-15 杨森制药公司 Hcv的大环蛋白酶抑制剂、非核苷hcv抑制剂和利托那韦的组合
WO2014152275A1 (en) * 2013-03-14 2014-09-25 Concert Pharmaceuticals, Inc. Deuterium modified derivatives of the ns5b polymerase inhibitor tmc647055
US10450263B2 (en) 2017-02-10 2019-10-22 Southern Research Institute Benzo annulenes as antiviral agents
KR101974388B1 (ko) 2017-06-23 2019-05-02 (주)에니켐텍 알킬 디에틸렌 트리아민 유도체 및 이의 제조방법
US11066357B2 (en) 2017-12-26 2021-07-20 Southern Research Institute Benzoannulene derivatives as antiviral agents

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007140200A2 (en) * 2006-05-25 2007-12-06 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037157A (en) 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
US5807876A (en) 1996-04-23 1998-09-15 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme
US6054472A (en) 1996-04-23 2000-04-25 Vertex Pharmaceuticals, Incorporated Inhibitors of IMPDH enzyme
US20050267836A1 (en) 1996-03-25 2005-12-01 Cfph, Llc Method and system for transacting with a trading application
CZ298463B6 (cs) 1996-04-23 2007-10-10 Vertex Pharmaceuticals Incorporated Deriváty mocoviny pro použití jako inhibitory IMPDH enzymu a farmaceutické prostredky, které je obsahují
WO1998040381A1 (en) 1997-03-14 1998-09-17 Vertex Pharmaceuticals Incorporated Inhibitors of impdh enzyme
EE200100492A (et) 1999-03-19 2002-12-16 Vertex Pharmaceuticals Incorporated Ensüümi IMPDH inhibiitorid
JP4778665B2 (ja) 2000-08-30 2011-09-21 パナソニック株式会社 プラズマディスプレイ表示装置の製造方法
DK1713823T3 (da) 2004-01-30 2010-03-08 Medivir Ab HCV NS-3 serinproteaseinhibitorer
US7153848B2 (en) 2004-08-09 2006-12-26 Bristol-Myers Squibb Company Inhibitors of HCV replication
PE20070211A1 (es) 2005-07-29 2007-05-12 Medivir Ab Compuestos macrociclicos como inhibidores del virus de hepatitis c
RU2008112661A (ru) 2005-09-02 2009-10-10 Тиботек Фармасьютикалз Лтд. (Ie) Бензодиазепины в качестве ингибиторов hcv
US7399758B2 (en) * 2005-09-12 2008-07-15 Meanwell Nicholas A Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
GB0522881D0 (en) 2005-11-10 2005-12-21 Angeletti P Ist Richerche Bio Therapeutic compounds
WO2007092000A1 (en) 2006-02-06 2007-08-16 Bristol-Myers Squibb Company Inhibitors of hcv replication
US7521443B2 (en) 2006-05-17 2009-04-21 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7456166B2 (en) * 2006-05-17 2008-11-25 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7521441B2 (en) 2006-05-22 2009-04-21 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
AP2009004812A0 (en) 2006-10-10 2009-04-30 Medivir Ab HCV nucleoside inhibitor
JP2010513450A (ja) 2006-12-20 2010-04-30 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー 抗ウイルス性インドール
WO2009010785A1 (en) 2007-07-17 2009-01-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Macrocyclic indole derivatives for the treatment of hepatitis c infections
TWI454476B (zh) 2008-07-08 2014-10-01 Tibotec Pharm Ltd 用作ｃ型肝炎病毒抑制劑之巨環吲哚衍生物
AR073603A1 (es) 2008-09-18 2010-11-17 Ortho Mcneil Janssen Pharm Combinaciones sinergicas de un inhibidor macrociclico del vhc y un nucleosido
RU2536868C2 (ru) 2009-02-27 2014-12-27 Орто-Макнейл-Янссен Фармасьютикалз Инк Аморфная соль макроциклического ингибитора hcv
KR20130057990A (ko) 2010-04-13 2013-06-03 얀센 파마슈티칼즈, 인코포레이티드 마크로사이클릭 ｈｃｖ 저해제, 비뉴클레오시드 및 뉴클레오시드의 배합물
US9127010B2 (en) 2010-06-24 2015-09-08 Janssen Sciences Ireland Uc Preparation of 13-cyclohexyl-3-methoxy-6-[methyl-(2-{2-[methyl-(sulphamoyl)-amino]-ethoxy}-ethyl)-carbamoyl]-7H-indolo-[2,1-a]-[2]-benzazepine-10-carboxylic acid
CN104780921A (zh) 2012-08-31 2015-07-15 杨森制药公司 Hcv的大环蛋白酶抑制剂、非核苷hcv抑制剂和利托那韦的组合

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007140200A2 (en) * 2006-05-25 2007-12-06 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors

Also Published As

Publication number Publication date
NI201100010A (es) 2011-09-07
US9427440B2 (en) 2016-08-30
EP2310396B1 (en) 2017-09-06
BRPI0915887B1 (pt) 2020-02-18
SV2011003796A (es) 2011-04-08
AU2009267389B2 (en) 2013-05-30
DK2310396T3 (en) 2017-12-11
WO2010003658A1 (en) 2010-01-14
AU2009267389B8 (en) 2013-07-04
CN102089314B (zh) 2014-07-23
CR20110076A (es) 2011-11-10
NO2310396T3 (hu) 2018-02-03
JP2014028818A (ja) 2014-02-13
IL210086A (en) 2014-05-28
JP5808370B2 (ja) 2015-11-10
HUE035244T2 (hu) 2018-05-02
ES2651038T3 (es) 2018-01-23
KR101640374B1 (ko) 2016-07-18
LT2310396T (lt) 2017-12-27
EA019008B1 (ru) 2013-12-30
HK1155734A1 (en) 2012-05-25
NZ590073A (en) 2012-11-30
US20140107101A1 (en) 2014-04-17
CL2011000032A1 (es) 2011-07-15
CN102089314A (zh) 2011-06-08
IL210086A0 (en) 2011-02-28
AR072726A1 (es) 2010-09-15
AU2009267389A8 (en) 2013-07-04
SI2310396T1 (en) 2018-01-31
US8921355B2 (en) 2014-12-30
UY31973A (es) 2010-01-29
KR20110040889A (ko) 2011-04-20
AP2010005521A0 (en) 2010-12-31
HN2011000072A (es) 2013-09-01
CA2729307C (en) 2017-08-29
JP5426671B2 (ja) 2014-02-26
EA201170153A1 (ru) 2011-08-30
US20110105473A1 (en) 2011-05-05
ECSP11010750A (es) 2011-08-31
JP2011527299A (ja) 2011-10-27
MX2011000276A (es) 2011-03-02
BRPI0915887A2 (pt) 2015-11-03
EP2310396A1 (en) 2011-04-20
TW201014865A (en) 2010-04-16
CA2729307A1 (en) 2010-01-14
TWI454476B (zh) 2014-10-01
BRPI0915887B8 (pt) 2021-05-25
CO6351793A2 (es) 2011-12-20
NZ603343A (en) 2013-08-30
HRP20171892T1 (hr) 2018-01-12
AU2009267389A1 (en) 2010-01-14

Similar Documents

Publication Publication Date Title
HRP20171892T1 (hr) Makrociklički derivati indola korisni kao inhibitori virusa hepatitisa c
HK1256310A1 (zh) N-磺酰基吡咯衍生物
PL2238142T3 (pl) Makrocykliczne indole jako inhibitory wirusa zapalenia wątroby typu C
IL207099A0 (en) 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of-??-secretase (bace)
PT2134685E (pt) Derivados de índole não substituídos na posição 7 como inibidores de mcl-1
IL210548A0 (en) Spiroaminodihydrothiazine derivatives
ZA201104361B (en) Substituted dioxopiperidinyl phthalimide derivatives
EP2376494A4 (en) DIHYDROPYRIMIDOPIRYMIDINE DERIVATIVES
ZA201100799B (en) Imidazopyridin-2-one derivatives
HK1148283A1 (en) Heterocyclic derivatives
EP2331543A4 (en) 3-DÉSAZANEPLANOCINE DERIVATIVES
HK1149762A1 (en) Substituted indole derivatives
ZA201100876B (en) Pyrrolopyridinylpyrimidin-2-ylamine derivatives
EP2291078A4 (en) OXAZOLBENZIMIDAZOLDERIVATE
IL211241A0 (en) 7-azaindole derivatives
EP2279532A4 (en) OXAZOLBENZIMIDAZOLDERIVATE
GB0905328D0 (en) Indole derivatives
IL210869A0 (en) Imidazothiadiazoles derivatives
IL208336A0 (en) Pyrisazinone derivatives
IL207192A0 (en) Substituted heteroarylamide diazepinopyrimidone derivatives
IL210164A0 (en) Thiazolylpiperidine derivatives
ZA201005381B (en) Substituted heteroarylamide oxazepinopyrimidone derivatives
PL2297115T3 (pl) Pochodne di-alkoksychinazolin jako inhibitory receptora KDR
IL208548A0 (en) 2-phenyl-4-cyclopropyl-pyrimidine derivatives
EP2292613A4 (en) DIHYDROINDOLINONDERIVATE